Pro 2013-021 (Jianfeng Group Corporate Bond Listing Announcement)-3
Release time:
2020-08-05
Section III Overview of Bond Issuance
1. Bond Name
Zhejiang Jianfeng Group Co., Ltd. 201 3 Corporate Bonds (Phase I) (hereinafter referred to as "13 Peak 01 " ).
2. Bond Issuance Approval Authority and Document No.
This issue of bonds has been approved by China Securities Regulatory Commission Securities Regulatory License [201 3 ] 595 .
Total 3. Bond Issue
The size of the bond issue is 3 .7 billion yuan.
4. The maturity of this bond variety
The maturity of this corporate bond is 5 years (with 3 end-of-year issuer interest rate increase option and investor resale option).
5. Bond Issuance Method and Issuance Object
(I) Issuance Method
This issue of bonds adopts a combination of online public offering for public investors and offline inquiry agreement placement for institutional investors. Online subscription is concluded in real time according to the principle of "time first" , and offline subscription is conducted in the form of the issuer and the sponsor (lead underwriter) sending a "Placing Payment Notice" to institutional investors or signing an "offline subscription agreement" with them.
(II) Issuing Object
() Online Issuing: Public Investors (except those prohibited by laws and regulations) who hold the securities accounts of A , B , D and F opened by the registration institution.
( 2 ) Offline: Institutional investors who open qualified securities accounts with a registrar (except where purchasers are prohibited by laws and regulations).
6. the lead underwriter and members of the underwriting syndicate
The bonds are underwritten by the sponsor (lead underwriter) Zheshang Securities Co., Ltd. by way of balance underwriting.
The sponsor and lead underwriter of the bonds are Zheshang Securities Co.
7. bond denominationcurrent bond denomination
100 yuan, issued at par value.
8. Bond Annual Interest Rate, Interest Rate and Debt Repayment MethodThe coupon rate of the current bond is
4.90 % , using single interest on an annual basis, excluding compound interest. Interest is paid once a year, the principal is repaid once due, and the last interest is paid with the payment of the principal. The interest payment and principal payment of the bonds shall be handled in accordance with the relevant business rules of the registered company.
The interest date of this bond is2013 6 April 5 , Interest Payment Date is 2006 to 2018 on June 6 5 of each year (in case of legal holidays or rest days postponed to the following 1 working days; No additional interest is charged for each interest payment). If the investor exercises the option of resale, the interest payment date for the resale of some bonds will be May 5 days of each year from 2014 to 2016 (in case of legal holidays or rest days, the interest payment will be postponed to 1 working days of the following ; No additional interest will be charged for each interest payment). The debt registration date for the interest payment of the bonds will be processed in accordance with the relevant regulations of the bond registration agency .
8. Credit Rating Agency and Bond Credit Rating
are comprehensively assessed by Joint Rating
. The credit rating of the current corporate bonds isAA + , and the main credit rating of the issuer is AA . 9. Guarantee
This
Company Bond is provided byTianjin Tianshili Group Co., Ltd. full unconditional and irrevocable joint and several liability guarantee . 10. Bond Trustee
Zheshang Securities Co., Ltd. .
11. Capital Verification of Raised Funds Confirmation
The total amount of bonds issued in this period is RMB 3
.2 billion yuan. The net raised funds after deducting the issuance expenses have been remitted to the bank account designated by the issuer on185 , June# , June 13 , 2013. Tianjian Certified Public Accountants (Special General Partnership) hired by the issuer has issued a capital verification report numbered Tianjian Inspection [2013]181 on the availability of the proceeds of the bonds. 12. Repurchase Transaction Arrangement
With the consent of the Shanghai Stock Exchange, a new pledge-type repurchase transaction can be carried out after the listing of the bonds. The specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of the registered company.Section IV Basic Information on Listing and Custody of Bonds
1. Basic Information on Listing of Current Corporate Bonds
With the consent of Shanghai Stock Exchange, this issue of bonds will be listed on Shanghai Stock Exchange from July 2
, 208 , 2013, 206
,. This issue of bonds is referred to as "13 Peak 01 " , and the securities code is "122227 " . The bonds have been applied to the Shanghai Stock Exchange, and new pledge repurchase transactions can be carried out after listing. The specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of China Securities Depository and Clearing Co., Ltd. 2. the basic situation of corporate bond custody According to the bond custody certificate provided by China Securities Depository and Clearing Co., Ltd. Shanghai Branch.
Section V Main Financial Status of the Issuer
Audit of the Financial Reports of the 1. Issuer in the Last Three Fiscal Years
The Financial Reports of the Company 2010
,2011 and
2012have been audited by Tianjian Certified Public Accountants (Special General Partnership), and issued respectively Tianjian Audit [2011]2058 , Tianjian Audit [2012]2018 and Tianjian Audit [2013]2818 standard unqualified audit reports. II. Financial and Accounting Data for the Last Three Years (I) Brief Consolidated Financial Statements
Brief Consolidated Balance Sheet
Unit: yuan
Project
| 2012 July | 31
2011 July | 31
2010 December July | 31
Total Current Assets |
| 598,184,425.67 |
679,445,334.64 |
583,348,017.58 |
Total Non-current Assets |
| 2,180,185,953.50 |
1,959,405,246.64 |
1,572,530,092.02 |
Assets |
| 2,778,370,379.17 |
2,638,850,581.28 |
2,155,878,109.60 |
current liabilities total |
| 1,013,708,681.11 |
893,010,462.35 |
,733, 298,189.60 |
total non-current liabilities |
| 118,223,645.25 |
189,908,882.59 |
164,905,055.88 |
liabilities total |
| 1,131,932,326.36 |
1,082,919,344.94 |
898,203,245.48 |
Total Shareholders' Equity Attributable to Parent Company |
| 1,514,999,218.55 |
1,420,100,618.20 |
1,157,941,656.48 |
|
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page